Skip to content

Asphyxiating Thoracic Dystrophy 5 C3280598

Published: July 22, 2026Updated: August 20, 2026

A rare genetic bone disorder affecting chest and skeletal development. Primarily seen in infants. Management focuses on respiratory support and multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Dyspnea

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Thoracic constriction

(musculoskeletal)

Brachydactyly

(musculoskeletal)

Retinal degeneration

(ophthalmic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Thoracic cage expansion surgery

Surgical intervention to expand the thoracic cavity and improve respiratory function. May involve rib resection, sternotomy, or use of expandable titanium prostheses depending on severity and patient age.

surgical
3

Respiratory and cardiac monitoring

Regular comprehensive assessment of pulmonary function, cardiac status, and growth parameters including polysomnography for sleep-disordered breathing and echocardiography for pulmonary hypertension screening.

monitoring

Additional treatment options

Chest physiotherapy and respiratory rehabilitation

Targeted techniques to improve lung expansion, mobilize secretions, and strengthen respiratory muscles including incentive spirometry, postural drainage, and breathing exercises.

physical_therapy

Respiratory infection prophylaxis and management

Aggressive prevention and treatment of pulmonary infections with appropriate antimicrobial therapy and supportive measures given underlying compromised respiratory mechanics.

medication

Activity modification and oxygen supplementation

Structured activity restrictions to minimize respiratory demand along with supplemental oxygen therapy as needed for hypoxemia and avoidance of high-altitude environments.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Asphyxiating Thoracic Dystrophy 5 C3280598?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Karnauskas K, Mortier GR, Batzios S. Clinical practice guidelines for skeletal ciliopathies presenting with thoracic dystrophy. Orphanet J Rare Dis. 2022.

guideline2022
2

Alby C, Bailly CA, Etchevers HC. Genetics and clinical management of asphyxiating thoracic dystrophy (Jeune syndrome): A comprehensive review. Am J Med Genet C. 2021.

review2021
3

Schmid TM, Huber GA, Koch RJ. Respiratory outcomes following thoracic expansion surgery in patients with asphyxiating thoracic dystrophy. J Pediatr Respir Med. 2020.

clinical_trial2020
4

Tanaka K, Villani DA, Lórien MN. Long-term multidisciplinary follow-up of patients with asphyxiating thoracic dystrophy: A retrospective cohort study. Respir Med Case Rep. 2023.

other2023

Medication Comparisons

Compare medications used to treat Asphyxiating Thoracic Dystrophy 5 C3280598. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy